Status:
COMPLETED
Correlation Between Body Composition and Pathologic Grade/Prognosis in GEP-NENs: A Retrospective Study
Lead Sponsor:
Tongji Hospital
Conditions:
Neuroendocrine Tumors
Eligibility:
All Genders
Brief Summary
The goal of this observational study is to learn about the value of body composition as predictors of pathological grading and prognosis in patients with gastroenteropancreatic neuroendocrine neoplasm...
Detailed Description
Objectives To explore the value of body composition parameters (BCPs) as predictors of pathological grading, prognosis in patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). Met...
Eligibility Criteria
Inclusion
- A confirmed diagnosis of GEP-NENs via histopathology with a WHO grading
- Available enhanced CT scans that included full abdominal imaging before surgery or biopsy
Exclusion
- Therapeutic interventions before surgery or biopsy
- Poor image quality or incomplete CT images of the whole abdomen
Key Trial Info
Start Date :
November 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 29 2025
Estimated Enrollment :
633 Patients enrolled
Trial Details
Trial ID
NCT06983106
Start Date
November 4 2024
End Date
March 29 2025
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030